Obstetrics/Gynecology · Chicago, IL
NPI
1962486001
Since 2005
Specialty
Obstetrics/Gynecology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
680 N Lake Shore Dr, Suite 824
Chicago, IL, 60611
Phone (813) 890-8004
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$64K
797 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Susan Shaw prescribed most often to Medicare patients was Estradiol, with 208 prescriptions and refills. In total Susan Shaw wrote 797 Medicare prescriptions that cost $64K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Estradiol Generic | 208 | 878 | 150 | $7,805 |
| Triamcinolone Acetonide Generic | 56 | 56 | 43 | $637 |
| Climara Estradiol | 51 | 134 | 22 | $6,756 |
| Yuvafem Estradiol | 50 | 134 | 35 | $5,516 |
| Clobetasol Propionate Generic | 47 | 47 | 37 | $780 |
| Progesterone Progesterone, Micronized | 42 | 134 | 24 | $2,242 |
| Estring Estradiol | 30 | 90 | 17 | $18K |
| Fluconazole Generic | 30 | 50 | 24 | $241 |
| Acyclovir Generic | 23 | 48 | 13 | $489 |
| Trospium Chloride Generic | 21 | 45 | 13 | $934 |
| Dotti Estradiol | 21 | 53 | 12 | $1,835 |
| Lidocaine Generic | 15 | 15 | Under 11 | $197 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 14 | 14 | 12 | $473 |
| Xulane Norelgestromin/Ethin.Estradiol | 13 | 13 | Under 11 | $1,764 |
| Hydrocortisone Generic | 12 | 13 | Under 11 | $153 |
Brand drugs: 101 claims; generic drugs: 696 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Susan Shaw were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.